Watch AFJK. Know when insiders buy.
One email the day a filing lands. Free.
AFJK
Aimei Health Technology Co., Ltd.
12.10
−0.17 −1.39%
USD · close Oct 20
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
24
FLAG · shorts 24
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $38.3MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME $412K −77.1%NET CASH —52W 8.00 – 88.50SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$192K | −$83K | −119.6% | — | −$157K | — | — | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$62K | $45K | −75.4% | — | −$75K | — | — | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$251K | $98K | −77.9% | — | −$43K | — | — | May 4 |
| Q3 2025 · Sep 30 | — | — | — | −$130K | $352K | −52.7% | — | −$96K | — | — | Nov 18 |
| Q2 2025 · Jun 30 | — | — | — | −$42K | $425K | −30.2% | — | −$202K | — | — | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$413K | $185K | −75.6% | — | −$224K | — | — | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$402K | $444K | — | — | −$195K | — | — | May 4 |
| Q3 2024 · Sep 30 | — | — | — | −$200K | $744K | — | — | −$54K | — | — | Nov 18 |
| Q2 2024 · Jun 30 | — | — | — | −$309K | $609K | — | — | −$256K | — | — | Nov 18 |
| Q1 2024 · Mar 31 | — | — | — | −$154K | $756K | — | — | −$167K | — | — | Nov 18 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$836K | $1.1M | — | — | −$565K | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$1.1M | $2.6M | — | — | −$672K | — | — | — | — |
| FY2023 · to Dec 31 | — | — | — | — | — | — | — | — | — | — | — |
Every number comes from Aimei Health Technology Co., Ltd.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.